Asthika Goonewardene

Stock Analyst at Truist Securities

(1.30)
# 3,429
Out of 4,842 analysts
95
Total ratings
36.47%
Success rate
-15.37%
Average return

Stocks Rated by Asthika Goonewardene

Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9$10
Current: $0.37
Upside: +2,632.99%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88$71
Current: $28.29
Upside: +150.97%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14$10
Current: $1.14
Upside: +777.19%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11$10
Current: $1.65
Upside: +506.06%
Genmab
Mar 11, 2025
Maintains: Buy
Price Target: $50$45
Current: $21.19
Upside: +112.36%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25$15
Current: $1.75
Upside: +757.14%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32$7
Current: $4.14
Upside: +69.29%
Exelixis
Jan 27, 2025
Maintains: Buy
Price Target: $42$43
Current: $42.41
Upside: +1.39%
IGM Biosciences
Jan 10, 2025
Maintains: Hold
Price Target: $12$2
Current: $1.23
Upside: +62.60%
BioNTech SE
Jan 10, 2025
Initiates: Buy
Price Target: $172
Current: $97.53
Upside: +76.36%
Initiates: Buy
Price Target: $35
Current: $26.04
Upside: +34.41%
Maintains: Buy
Price Target: $87$136
Current: $61.17
Upside: +122.33%
Maintains: Hold
Price Target: $83$97
Current: $108.44
Upside: -10.55%
Maintains: Buy
Price Target: $18$15
Current: $0.92
Upside: +1,538.09%
Maintains: Buy
Price Target: $50$44
Current: $9.13
Upside: +381.93%
Maintains: Buy
Price Target: $69$88
Current: $50.01
Upside: +75.96%
Maintains: Buy
Price Target: $5$4
Current: $1.45
Upside: +175.86%
Maintains: Buy
Price Target: $19
Current: $1.12
Upside: +1,596.43%
Reiterates: Buy
Price Target: $40
Current: $1.58
Upside: +2,431.65%
Reiterates: Buy
Price Target: $27
Current: $0.65
Upside: +4,034.76%
Reinstates: Hold
Price Target: $120
Current: $26.75
Upside: +348.60%
Maintains: Hold
Price Target: $100$60
Current: $2.35
Upside: +2,453.19%
Maintains: Buy
Price Target: $19$15
Current: $0.47
Upside: +3,115.43%